A serum creatinine measurement is not performed in about one-quarter of diabetes patients prior to starting metformin therapy, according to the results of a new Canadian study.
New CMAJ study suggests that telmisartan or valsartan may be the preferred angiotensin receptor blockers for preventing cardiovascular events in patients with diabetes.